Key Points 1. Recurrence of hepatitis C infection is universal and immediate after liver
transplantation. 2. Graft and patient survival is reduced in liver transplantation recipients with …

Hepatitis C virus (HCV)‐related end‐stage liver disease is the main indication for liver
transplantation performed in Europe and the United States. Recurrence of hepatitis C in the …

Cytomegalovirus (CMV) causes considerable morbidity and mortality in orthotopic liver
transplant (OLT) recipients. Several prophylactic strategies against CMV have been studied …

Post‐transplantation recurrence is increasing in patients with HCV. Early antiviral therapy
may be of benefit in this setting. Thus, accurate and early prediction of progression may help …

Abstract Cytomegalovirus (CMV)-seronegative recipients (R-) of a liver transplant from CMV-
positive donors (D+) are at high risk for developing late CMV disease after discontinuation of …

Cytomegalovirus (CMV) infection is a common complication after liver transplantation, and it
is associated with multiple direct and indirect effects. Management of CMV infection and …

Cytomegalovirus (CMV) infection is the most common viral infection in liver transplant
recipients, affecting post-transplant patients and graft survival. Recent advances in …

BACKGROUND/AIMS: HCV infection recurs almost in all HCV-positive patients receiving
liver transplantation and carries a poor prognosis. Aim of this study was to analyze efficacy …

The outcome ofde novohepatitis C virus (HCV) infection in heart transplant recipients of HCV‐
antibody positive organs is not known. The aim of the study was to determine the short‐term …

In HCV cirrhotic patients after liver transplantation, survival and recurrence of HCV appears
to be worsening in recent years. Donor age has been suggested as a cause. However, it is …